Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: two case reports

BACKGROUND: Intravenous enzyme replacement therapy is a first-line therapy for Gaucher disease type 1, and substrate reduction therapy represents an oral treatment alternative. Both enzyme replacement therapy and substrate reduction therapy are generally used as monotherapies in Gaucher disease. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Amato, Dominick, Patterson, Mary Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787317/
https://www.ncbi.nlm.nih.gov/pubmed/29373994
http://dx.doi.org/10.1186/s13256-017-1541-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787317/
https://www.ncbi.nlm.nih.gov/pubmed/29373994
http://dx.doi.org/10.1186/s13256-017-1541-7

Ejemplares similares